The role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trials | Zendy

Rong-Hua Tian | Zendy; Xia Wu | Zendy; Xia Liu | Zendy; Jin-Wang Yang | Zendy; Hua-Liang Ji | Zendy; Yongjin Yan | Zendy

Open Access

The role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trials

Author(s) -

Rong-Hua Tian,

Xia Wu,

Xia Liu,

Jin-Wang Yang,

Hua-Liang Ji,

Yongjin Yan

Publication year - 2016

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.151950

Subject(s) - medicine , hazard ratio , oncology , lung cancer , meta analysis , randomized controlled trial , subgroup analysis , clinical trial , publication bias , confidence interval , progression free survival , overall survival

Data on the role of angiogenesis inhibitors (AIs) in the treatment of elderly patients with advanced non-small-cell lung cancer (NSCLC) remains limited. We aimed to assess the overall efficacy of AIs-containing regimens in the treatment of advanced NSCLC in this setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research